Factor | Ovulation disorders | Normo- ovulation | P value | OR (95% CI) |
---|---|---|---|---|
No. of IVF cycles (n) | 90 | 303 | ||
Female age (y) | 30.4 ± 3.7 | 31.2 ± 4.4 | 0.086b | 1.051(0.993–1.112) |
Female BMI (kg/m2) | 22.6 ± 3.9 | 22.2 ± 3.0 | 0.388 b | 0.969(0.901–1.041) |
Infertility | ||||
 Primary | 52 | 139 | 0.047a | |
 Secondary | 38 | 164 | ||
Starting dose of Gn(U) | 197.0 ± 48.0 | 227.2 ± 52.0 | < 0.0001 b | 1.012(1.007–1.017) |
Days of stimulation | 10.1 ± 1.8 | 10.9 ± 1.9 | < 0.0001 b | 1.292(1.120–1.490) |
Total dose of Gn(U) | 2036.6 ± 790.2 | 2602.1 ± 785.3 | < 0.0001 b | 1.001(1.001–1.001) |
b-FSH (mIU/ml) | 7.1 ± 2.4 | 8.0 ± 2.1 | 0.002 b | 1.206(1.068–1.362) |
b-LH (mIU/ml) | 7.5 ± 4.5 | 4.6 ± 2.7 | < 0.0001 b | 0.771(0.706–0.843) |
b-FSH/bLH | 1.3 ± 1.5 | 2.1 ± 1.4 | < 0.0001 b | 3.019(2.021–4.511) |
AFC (n) | 20.2 ± 9.5 | 13.8 ± 6.6 | < 0.0001 b | 0.894(0.861–0.929) |
AMH (ng/ml) | 7.4 ± 4.1 | 3.8 ± 2.2 | < 0.0001 b | 0.653(0.588–0.727) |
No. of oocytes retrieved | 17.1 ± 7.1 | 13.8 ± 7.4 | < 0.0001 b | 0.943(0.914–0.973) |
Male age (y) | 33.1 ± 5.3 | 33.9 ± 5.5 | 0.248 b | 1.207(0.982–1.075) |
Sperm concentration (106/ml) | 94.2 ± 63.7 | 96.6 ± 66.3 | 0.760 b | 1.001(0.997–1.004) |
Semen round cells (106/ml) | 0.59 ± 1.8 | 0.52 ± 0.7 | 0.739 b | 0.968(0.800–1.172) |
Progressive motility (%) | 58.6 ± 15.3 | 56.7 ± 15.1 | 0.306 b | 0.992(0.976–1.008) |
Normal morphology (%) | 7.8 ± 6.6 | 7.1 ± 3.9 | 0.216 b | 0.971(0.926–1.018) |
Sperm mitochondrial ROS rate (%) | 3.3 ± 2.4 | 3.4 ± 2.5 | 0.789 b | 1.013(0.921–1.114) |
Sperm hydrogen peroxide rate (%) | 0.5 ± 0.4 | 0.5 ± 0.5 | 0.420 b | 1.242(0.734–2.103) |
Fertilization rate (%) | 88.2 ± 15.9 | 89.0 ± 14.6 | 0.644 b | 1.433(0.311–6.597) |
2PN rate (%) | 68.9 ± 21.1 | 73.3 ± 18.4 | 0.055 b | 3.212(0.973–10.602) |
≥3PN rate (%) | 9.2 ± 10.7 | 9.2 ± 11.5 | 0.968 b | 0.958(0.120–8.657) |
Cleavage rate (%) | 96.6 ± 19.9 | 97.4 ± 18.9 | 0.669 b | 1.352(0.340–5.375) |
Day 2 Embryo development rate (%) | 57.7 ± 27.9 | 56.3 ± 25.7 | 0.655 b | 0.812(0.326–2.023) |
Day 3 Embryo development rate (%) | 38.8 ± 25.7 | 40.5 ± 26.5 | 0.605 b | 1.271(0.512–3.154) |
Day 3 Embryo utilization rate (%) | 58.3 ± 19.5 | 61.6 ± 20.5 | 0.179 b | 2.205(.697–6.980) |
Good-quality day 3 embryo rate (%) | 30.5 ± 20.5 | 33.7 ± 21.1 | 0.204 b | 2.115(0.666–6.717) |
D5 Blastocyst utilization rate (%) | 33.9 ± 26.7 | 30.7 ± 25.9 | 0.091 b | 0.223(0.089–0.557) |
D5 Good-quality blastocysts rate (%) | 29.6 ± 24.5 | 27.7 ± 24.0 | 0.105 b | 0.247(0.092–0.662) |
D6 Blastocyst utilization rate (%) | 28.2 ± 20.3 | 30.7 ± 27.8 | 0.473 b | 1.434(0.535–3.844) |
D6 Good-quality blastocysts rate (%) | 21.6 ± 18.1 | 22.4 ± 24.9 | 0.788 b | 1.161(0.391–3.449) |
Blastocyst development rate (%) | 66.8 ± 25.0 | 63.1 ± 32.0 | 0.352 b | 0.668(0.286–1.562) |
Blastocyst utilization rate (%) | 59.4 ± 23.4 | 53.4 ± 31.5 | 0.125 b | 0.508(0.214–1.206) |
Good-quality blastocyst rate (%) | 51.2 ± 24.2 | 46.2 ± 29.7 | 0.080 b | 0.374(0.154–0.911) |